| 1 | Gastric autoimmune disorders in patients with chronic hepatitis C before,during and after interferon-alpha therapy显示文摘AIM: To explore the prevalence of autoimmune gastritis in chronic hepatitis C virus (HCV) patients and the influence of α-intefferon (IFN) treatment on autoimmune gastritis.METHODS: We performed a prospective study on 189patients with positive anti-HCV and viral RNA enrolled in a 12-month IFN protocol. We evaluated: a) the baseline prevalence of autoimmune gastritis, b) the impact of IFN treatment on development of biochemical signs of autoimmune gastritis (at 3, 6 and 12 months), c) the evolution after IFN withdrawal (12 months) in terms of anti-gastric-parietal-cell antibodies (APCA), gastrin, anti-thyroid, and anti-non-organ-specific antibodies.RESULTS: APCA positivity and 3-fold gastrin levels were detected in 3 (1.6 %) and 9 (5 %) patients, respectively, at baseline, in 25 (13 %) and 31 (16 %) patients at the end of treatment (both P<0.001, vs baseline), and in 7 (4 %) and 14 (7 %) patients 12 months after withdrawal (P=0.002and ,P=0.01 respectively, vs baseline; P=not significant vs end of treatment). The development of autoimmune gastritis was strictly associated with the presence of autoimmune thyroiditis (P =0.0001), no relationship was found with other markers of autoimmunity.CONCLUSION: In HCV patients, IFN frequently precipitates latent autoimmune gastritis, particularly in females. Following our 12-month protocol, the phenomenon generally regressed. Since APCA positivity and high gastrin levels are associated with the presence of antithyroid antibodies,development of autoimmune thyroiditis during IFN treatment may provide a surrogate preliminary indicator of possible autoimmune gastritis to limit the need for invasive examinations. | Carlo Fabbri M.Francesca Jaboli Silvia Giovanelli Francesco Azzaroli Alessandro Pezzoli Esterita Accogli Stefania Liva Giovanni Nigro Anna Miracolo Davide Festi Antonio Colecchia Marco Montagnani Enrico Roda Giuseppe Mazzella | 2003 | World Journal of Gastroenterology2003，9，7： | 3 |
| 4 | 应用微螺钉作为非牙性支抗的临床应用及疗效显示文摘目的介绍一种新型微螺钉种植体支抗在不同临床条件下的应用情况。材料与方法12名存在支抗控制问题的患者(13~52岁,3名男性,9名女性),治疗前获取患者的头颅侧位片,曲面断层片,照片及研究模型。根据相应的标准,确定每个患者不同的植入位置。共计植入19枚微螺钉,以实现不同类型的牙齿移动。
结果微螺钉的应用在多种不同的临床条件下都获得成功,例如:压低前牙,压低后牙,伸长并排齐阻生牙,作为远中移动牙齿的支抗,作为远中移动后的保持,前移磨牙,在后牙支抗不足的情况下用以内收上下颌前牙,在后牙缺失时唇倾并压低下颌前牙以及在关闭间隙过程中加强后牙支抗。
结论本研究所展示的新型的微螺钉作为一种非牙性支抗,在很多传统支抗无法应用的情况下显示了优良的治疗效率。 | Arturo Fortini Vittorio Cacciafesta M.Francesca Sfondrini Stefano Cambi Massimo Lupoli 朱胜吉(译) 傅民魁(校) | 2005 | 中国口腔医学继续教育杂志2005，8，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员